Abstract:
BACKGROUND:Evidence on where in the hypertension care process individuals are lost to care, and how this varies among states and population groups in a country as large as India, is essential for the design of targeted interventions and to monitor progress. Yet, to our knowledge, there has not yet been a nationally representative analysis of the proportion of adults who reach each step of the hypertension care process in India. This study aimed to determine (i) the proportion of adults with hypertension who have been screened, are aware of their diagnosis, take antihypertensive treatment, and have achieved control and (ii) the variation of these care indicators among states and sociodemographic groups. METHODS AND FINDINGS:We used data from a nationally representative household survey carried out from 20 January 2015 to 4 December 2016 among individuals aged 15-49 years in all states and union territories (hereafter "states") of the country. The stages of the care process-computed among those with hypertension at the time of the survey-were (i) having ever had one's blood pressure (BP) measured before the survey ("screened"), (ii) having been diagnosed ("aware"), (iii) currently taking BP-lowering medication ("treated"), and (iv) reporting being treated and not having a raised BP ("controlled"). We disaggregated these stages by state, rural-urban residence, sex, age group, body mass index, tobacco consumption, household wealth quintile, education, and marital status. In total, 731,864 participants were included in the analysis. Hypertension prevalence was 18.1% (95% CI 17.8%-18.4%). Among those with hypertension, 76.1% (95% CI 75.3%-76.8%) had ever received a BP measurement, 44.7% (95% CI 43.6%-45.8%) were aware of their diagnosis, 13.3% (95% CI 12.9%-13.8%) were treated, and 7.9% (95% CI 7.6%-8.3%) had achieved control. Male sex, rural location, lower household wealth, and not being married were associated with greater losses at each step of the care process. Between states, control among individuals with hypertension varied from 2.4% (95% CI 1.7%-3.3%) in Nagaland to 21.0% (95% CI 9.8%-39.6%) in Daman and Diu. At 38.0% (95% CI 36.3%-39.0%), 28.8% (95% CI 28.5%-29.2%), 28.4% (95% CI 27.7%-29.0%), and 28.4% (95% CI 27.8%-29.0%), respectively, Puducherry, Tamil Nadu, Sikkim, and Haryana had the highest proportion of all adults (irrespective of hypertension status) in the sampled age range who had hypertension but did not achieve control. The main limitation of this study is that its results cannot be generalized to adults aged 50 years and older-the population group in which hypertension is most common. CONCLUSIONS:Hypertension prevalence in India is high, but the proportion of adults with hypertension who are aware of their diagnosis, are treated, and achieve control is low. Even after adjusting for states' economic development, there is large variation among states in health system performance in the management of hypertension. Improvements in access to hypertension diagnosis and treatment are especially important among men, in rural areas, and in populations with lower household wealth.
journal_name
PLoS Medjournal_title
PLoS medicineauthors
Prenissl J,Manne-Goehler J,Jaacks LM,Prabhakaran D,Awasthi A,Bischops AC,Atun R,Bärnighausen T,Davies JI,Vollmer S,Geldsetzer Pdoi
10.1371/journal.pmed.1002801subject
Has Abstractpub_date
2019-05-03 00:00:00pages
e1002801issue
5eissn
1549-1277issn
1549-1676pii
PMEDICINE-D-18-04125journal_volume
16pub_type
杂志文章相关文献
PLOS MEDICINE文献大全abstract:BACKGROUND:For more than a decade, most parts of Somalia have not been under the control of any type of government. This "failure of state" is complete in the central and southern regions and most apparent in Mogadishu, which had been for a long period in the hands of warlords deploying their private militias in a batt...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0040341
更新日期:2007-12-01 00:00:00
abstract:BACKGROUND:Tissue advanced glycation end product (AGE) accumulation has been proposed as a marker of cumulative metabolic stress that can be assessed noninvasively by measurement of skin autofluorescence (SAF). In persons on haemodialysis, SAF is an independent risk factor for cardiovascular events (CVEs) and all-cause...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003163
更新日期:2020-07-13 00:00:00
abstract:BACKGROUND:Meta-analyses of antidepressant medications have reported only modest benefits over placebo treatment, and when unpublished trial data are included, the benefit falls below accepted criteria for clinical significance. Yet, the efficacy of the antidepressants may also depend on the severity of initial depress...
journal_title:PLoS medicine
pub_type: 杂志文章,meta分析
doi:10.1371/journal.pmed.0050045
更新日期:2008-02-01 00:00:00
abstract:BACKGROUND:Ovarian cancer kills approximately 15,000 women in the United States every year, and more than 140,000 women worldwide. Most deaths from ovarian cancer are caused by tumors of the serous histological type, which are rarely diagnosed before the cancer has spread. Rational design of a potentially life-saving e...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1000114
更新日期:2009-07-01 00:00:00
abstract:BACKGROUND:Drug manufacturers have developed "evergreening" strategies to compete with generic medication after patent termination. These include marketing of slightly modified follow-on drugs. We aimed to estimate the financial impact of these drugs on overall healthcare costs and also to examine the impact of listing...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001460
更新日期:2013-01-01 00:00:00
abstract:BACKGROUND:The National Health Service (NHS) in England introduced a population-wide programme for cardiovascular disease (CVD) prevention in 2009, known as NHS Health Checks. This research aimed to measure the cardiovascular risk management and cardiovascular risk factor outcomes of the health check programme during s...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002863
更新日期:2019-07-30 00:00:00
abstract::Mirjam Kretzschmar and colleagues describe the BCoDE project, which uses a pathogen-based incidence approach to better estimate the infectious disease burden in Europe. ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001205
更新日期:2012-01-01 00:00:00
abstract:BACKGROUND:The global tuberculosis epidemic results in nearly 2 million deaths and 9 million new cases of the disease a year. The vast majority of tuberculosis patients live in developing countries, where the diagnosis of tuberculosis relies on the identification of acid-fast bacilli on unprocessed sputum smears using ...
journal_title:PLoS medicine
pub_type: 杂志文章,meta分析,评审
doi:10.1371/journal.pmed.0040202
更新日期:2007-06-01 00:00:00
abstract:BACKGROUND:Animal studies suggest vital roles of sphingolipids, especially ceramides, in the pathogenesis of type 2 diabetes (T2D) via pathways involved in insulin resistance, β-cell dysfunction, and inflammation, but human studies are limited. We aimed to evaluate the associations of circulating sphingolipids with inc...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003451
更新日期:2020-12-09 00:00:00
abstract:BACKGROUND:Although the involvement of intra-tumor genetic heterogeneity in tumor progression, treatment resistance, and metastasis is established, genetic heterogeneity is seldom examined in clinical trials or practice. Many studies of heterogeneity have had prespecified markers for tumor subpopulations, limiting thei...
journal_title:PLoS medicine
pub_type: 杂志文章,多中心研究
doi:10.1371/journal.pmed.1001786
更新日期:2015-02-10 00:00:00
abstract:BACKGROUND TO THE DEBATE:The tobacco control community is divided on whether or not to inform the public that using oral, smokeless tobacco (Swedish snus) is less hazardous to health than smoking tobacco. Proponents of "harm reduction" point to the Swedish experience. Snus seems to be widely used as an alternative to c...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0040185
更新日期:2007-07-01 00:00:00
abstract:BACKGROUND:In June 2016, the first phase of the Chilean Food Labelling and Advertising Law that mandated front-of-package warning labels and marketing restrictions for unhealthy foods and beverages was implemented. We assess foods and beverages reformulation after this initial implementation. METHODS AND FINDINGS:A da...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003220
更新日期:2020-07-28 00:00:00
abstract::In this month's editorial, the PLOS Medicine Editors discuss the role of preprints in human health research and propose a 3-part framework for ensuring benefit. ...
journal_title:PLoS medicine
pub_type: 评论,社论
doi:10.1371/journal.pmed.1002563
更新日期:2018-04-16 00:00:00
abstract::Drawing upon interviews with experts and a review of the literature, Gavin Yamey proposes a new framework for scaling up global health interventions. ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1001049
更新日期:2011-06-01 00:00:00
abstract:BACKGROUND:Rare diseases affect as many as 60 million people in the United States and Europe. However, most rare diseases lack effective therapies and are in critical need of clinical research. Our objective was to determine the frequency of noncompletion and nonpublication of trials studying rare diseases. METHODS AN...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002966
更新日期:2019-11-21 00:00:00
abstract::The PLOS Medicine editors discuss the new extension to the PRISMA reporting guidelines, PRISMA for Equity (PRISMA-E), and why it is relevant to the journal and to health research more generally. ...
journal_title:PLoS medicine
pub_type: 社论
doi:10.1371/journal.pmed.1001334
更新日期:2012-10-01 00:00:00
abstract:BACKGROUND:Identifying stage II patients with colorectal cancer (CRC) at higher risk of progression is a clinical priority in order to optimize the advantages of adjuvant chemotherapy while avoiding unnecessary toxicity. Recently, the intensity and the quality of the host immune response in the tumor microenvironment h...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003292
更新日期:2020-09-24 00:00:00
abstract:BACKGROUND:Antenatal corticosteroid therapy (ACT) is used clinically to prepare the fetal lung for impending preterm birth, but animal and human studies link corticosteroids to smaller birth size. Whether ACT is associated with birth size is debated; therefore, we assessed differences in birth size in treated versus un...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002746
更新日期:2019-02-26 00:00:00
abstract:BACKGROUND:Four studies previously indicated that the effect of malaria infection during pregnancy on the risk of low birthweight (LBW; <2,500 g) may depend upon maternal nutritional status. We investigated this dependence further using a large, diverse study population. METHODS AND FINDINGS:We evaluated the interacti...
journal_title:PLoS medicine
pub_type: 杂志文章,meta分析
doi:10.1371/journal.pmed.1002373
更新日期:2017-08-08 00:00:00
abstract:BACKGROUND:Despite repeated outbreaks, in particular the devastating 2014-2016 epidemic, there is no effective treatment validated for patients with Ebola virus disease (EVD). Among the drug candidates is the broad-spectrum polymerase inhibitor favipiravir, which showed a good tolerance profile in patients with EVD (JI...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002535
更新日期:2018-03-27 00:00:00
abstract:BACKGROUND:Very-low-birth-weight (VLBW, <1,500 g) infants have compromised bone mass accrual during childhood, but it is unclear whether this results in subnormal peak bone mass and increased risk of impaired skeletal health in adulthood. We hypothesized that VLBW is associated with reduced bone mineral density (BMD) i...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1000135
更新日期:2009-08-01 00:00:00
abstract:BACKGROUND:There is growing concern that racial and ethnic minority communities around the world are experiencing a disproportionate burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19). We investigated racial and ethnic disparities in patterns of COVI...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003379
更新日期:2020-09-22 00:00:00
abstract:BACKGROUND:Diabetes is a well-known risk factor for tuberculosis (TB) and is increasingly prevalent in low- and middle-income countries, where the burden of TB is high. Glycemic control has the potential to modify the risk of TB. However, there are few studies on the association between glycemic control and TB risk, an...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1002072
更新日期:2016-08-09 00:00:00
abstract:BACKGROUND:Bilharzia is one of the major parasitic infections affecting the public health and socioeconomic circumstances in (sub) tropical areas. Its causative agents are schistosomes. Since these worms remain in their host for decades, they have developed mechanisms to evade or resist the immune system. Like several ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0030253
更新日期:2006-08-01 00:00:00
abstract:BACKGROUND:Immunohistochemical markers are often used to classify breast cancer into subtypes that are biologically distinct and behave differently. The aim of this study was to estimate mortality for patients with the major subtypes of breast cancer as classified using five immunohistochemical markers, to investigate ...
journal_title:PLoS medicine
pub_type: 杂志文章,meta分析
doi:10.1371/journal.pmed.1000279
更新日期:2010-05-25 00:00:00
abstract:BACKGROUND:Leber congenital amaurosis (LCA) is a genetically heterogeneous group of retinal diseases that cause congenital blindness in infants and children. Mutations in the GUCY2D gene that encodes retinal guanylate cyclase-1 (retGC1) were the first to be linked to this disease group (LCA type 1 [LCA1]) and account f...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0030201
更新日期:2006-06-01 00:00:00
abstract:BACKGROUND:Midwifery continuity of care is the only health system intervention shown to reduce preterm birth (PTB) and improve perinatal survival, but no trial evidence exists for women with identified risk factors for PTB. We aimed to assess feasibility, fidelity, and clinical outcomes of a model of midwifery continui...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.1003350
更新日期:2020-10-06 00:00:00
abstract:BACKGROUND:Although it has long been appreciated that ovarian carcinoma subtypes (serous, clear cell, endometrioid, and mucinous) are associated with different natural histories, most ovarian carcinoma biomarker studies and current treatment protocols for women with this disease are not subtype specific. With the emerg...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0050232
更新日期:2008-12-02 00:00:00
abstract::Considerable progress has been made in reducing maternal, newborn, and child mortality worldwide, but many more deaths could be prevented if effective interventions were available to all who could benefit from them. Timely, high-quality measurements of intervention coverage--the proportion of a population in need of a...
journal_title:PLoS medicine
pub_type: 杂志文章,评审
doi:10.1371/journal.pmed.1001423
更新日期:2013-01-01 00:00:00
abstract:BACKGROUND:The contribution of low-penetrant susceptibility variants to cancer is not clear. With the aim of searching for genetic factors that contribute to cancer at one or more sites in the body, we have analyzed familial aggregation of cancer in extended families based on all cancer cases diagnosed in Iceland over ...
journal_title:PLoS medicine
pub_type: 杂志文章
doi:10.1371/journal.pmed.0010065
更新日期:2004-12-01 00:00:00